Back to Search
Start Over
A randomized, open-label, phase II open platform study evaluating the efficacy and safety of novel spartalizumab (PDR001) combinations in previously treated unresectable or metastatic melanoma (PLATForM)
- Source :
- Annals of Oncology. 29:viii465-viii466
- Publication Year :
- 2018
- Publisher :
- Elsevier BV, 2018.
Details
- ISSN :
- 09237534
- Volume :
- 29
- Database :
- OpenAIRE
- Journal :
- Annals of Oncology
- Accession number :
- edsair.doi.dedup.....ef3c3f56a5dfe11c3114f8e86ce410ea